CVRx (CVRX) Current Leases (2022 - 2026)

CVRx's (CVRX) quarterly Current Leases came in at $361000.0 in Q1 2026, up 24.48% year-on-year from $290000.0 in Q1 2025, and up 2.56% quarter-over-quarter from $352000.0 in Q4 2025.

CVRx (CVRX) Current Leases (2022 - 2026) Analysis & Trends

CVRx's Current Leases history runs 5 years deep, the most recent figure standing at $361000.0 for Q1 2026.

  • On a quarterly basis, Current Leases rose 24.48% year-over-year to $361000.0 in Q1 2026; TTM through Mar 2026 was $361000.0, a 24.48% increase from a year earlier, with the FY2025 full-year figure at $352000.0, up 24.82% from the prior year.
  • Current Leases advanced to $361000.0 in Q1 2026 per CVRX's latest filing, from $352000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $361000.0 in Q1 2026 and bottomed at $170000.0 in Q3 2023.
  • The 5-year median for Current Leases is $247000.0 (2024), against an average of $264266.7.
  • Across the five-year window, Current Leases grew 4.05% in 2023 and surged 61.76% in 2024, its largest moves.
  • Year by year, Current Leases stood at $222000.0 in 2022, then rose by 4.05% to $231000.0 in 2023, then gained by 22.08% to $282000.0 in 2024, then rose by 24.82% to $352000.0 in 2025, then gained by 2.56% to $361000.0 in 2026.
  • Per Business Quant, the three latest CVRX Current Leases figures stand at $361000.0 (Q1 2026), $352000.0 (Q4 2025), and $342000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn 361,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 361,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 342,000.00
Jun 30, 2025 333,000.00
Mar 31, 2025 290,000.00
Dec 31, 2024 282,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 247,000.00
Mar 31, 2024 239,000.00
Dec 31, 2023 231,000.00
Sep 30, 2023 170,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 227,000.00
Dec 31, 2022 222,000.00
Mar 31, 2022 208,000.00